Evidence Hub

From herb to headache relief: A network-based study on Origanum vulgare L․

Samin Sheikholeslami, SeyedehNazanin Sadroleslami, Atefeh Hajiagha Bozorgi, Mohammad Mahdi Ahmadian-Attari

Pharmacological Research - Modern Chinese Medicine, 2026

Abstract

• Oregano compounds showed strong multi-target potential against migraine pathways. • Luteolin, apigenin, and rosmarinic acid exhibited high docking affinities. • Essential oil terpenoids showed broad interactions with migraine-related targets. • Network pharmacology revealed key nodes regulating neurovascular migraine mechanisms. • Results support Origanum vulgare as a promising complementary migraine therapy. Migraine is a complex neurological disorder characterized by recurrent headaches influenced by genetic, hormonal, vascular, and neuroinflammatory factors. Key proteins such as NOS3, DRD2, ESR1, HTR2A, CACNA1A, TRPV1, and CALCA regulate vascular tone, neurotransmission, hormonal balance, and pain signaling. Origanum vulgare L. (oregano), recognized in modern Chinese medicine as Niu Zhi (牛至), is recorded as Herba Origani Vulgaris and has documented traditional indications including heat-clearing, dampness-draining, and treatment of fever/heat-stroke–type conditions. Modern pharmacological evidence further supports anti-inflammatory, antioxidant, analgesic, and neuroprotective activities, largely attributed to phenolic monoterpenes (e.g., carvacrol, thymol) and polyphenols (e.g., rosmarinic acid, flavonoids). However, its molecular mechanisms in migraine-related neurovascular and neuroinflammatory pathways remain insufficiently characterized . This study investigated the therapeutic potential of oregano-derived bioactive compounds against migraine using an integrative in…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free